CD44-IR700-mediated PIT also decreased CD31 expression levels indicating significant destruction of vasculature that may have also contributed to the profound decrease of tumor growth and catastrophic cell death in the CD44 positive treated tumors. The gene discussed is PECAM1; the disease is neoplasm.